Demographic characterization of Brazilian patients enrolled in the Fabry Registry

被引:9
作者
Martins, A. M. [1 ]
Kyosen, S. O. [1 ]
Garrote, J. [1 ]
Marques, F. M. V. [2 ]
Guilhem, J. G. [3 ]
Macedo, E. [4 ]
Sobral Neto, J. [5 ]
Ura, S. [6 ]
机构
[1] Univ Fed Sao Paulo, Dept Pediat, Ctr Referencia Erros Inatos Metab, Sao Paulo, Brazil
[2] Hosp Santo Antonio, Tapejara, RS, Brazil
[3] Inst Hemodialise Sorocaba, Sorocaba, SP, Brazil
[4] Ctr Infusao Doencas Raras, Curimata, PI, Brazil
[5] Ctr Avaliacao Cardiol, Ctr Card, Brasilia, DF, Brazil
[6] Inst Lauro de Souza Lima, Bauru, SP, Brazil
关键词
Fabry disease; Alpha-galactosidase A deficiency; Fabry Registry; Brazil; Demographics; DISEASE; FEMALES;
D O I
10.4238/2013.January.24.5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fabry disease (FD) is an X-linked inborn error of metabolism caused by alpha-galactosidase A deficiency. The Fabry Registry is an ongoing observational database that compiles clinical data on patients with FD. We analyzed the Fabry Registry data of patients enrolled in Brazil to characterize the demographic and baseline clinical characteristics of this patient population. As of October 2010, 126 Brazilian patients were enrolled in the Registry (61 males, 65 females). The median age at onset of symptoms in males was 9.8 years, compared to 11.4 years in females. Males were diagnosed at a median age of 31.9 years and females at 27.1 years. The median time between the onset of first symptoms and diagnosis was 20.3 years in males and 14.3 years in females. Neurologic pain was the presenting symptom most frequently reported by both genders. Renal events were the most common clinical events reported in males, while cardiac events were the most common events in females. The results of these analyses indicate that Brazilian patients were frequently not diagnosed with FD until many years after the onset of symptoms. Many Brazilian Fabry Registry patients report experiencing neurological pain, and many Brazilian women with FD exhibit substantial signs and symptoms. The prevalence of neurological pain as a presenting symptom among Brazilian Registry patients is consistent with previous reports from the overall Registry population. FD is treatable, and earlier diagnosis will allow for prompt initiation of appropriate treatment that may avert irreversible damage that could occur during the time from symptom onset to diagnosis.
引用
收藏
页码:136 / 142
页数:7
相关论文
共 50 条
  • [41] Risk factors for severe clinical events in male and female patients with Fabry disease treated with agalsidase beta enzyme replacement therapy: Data from the Fabry Registry
    Hopkin, Robert J.
    Cabrera, Gustavo
    Charrow, Joel
    Lemay, Roberta
    Martins, Ana Maria
    Mauer, Michael
    Ortiz, Alberto
    Patel, Manesh R.
    Sims, Katherine
    Waldek, Stephen
    Warnock, David G.
    Wilcox, William R.
    MOLECULAR GENETICS AND METABOLISM, 2016, 119 (1-2) : 151 - 159
  • [42] Clinical Outcomes of People With Fabry Disease - ANZDATA Registry Study
    Ng, Monica S.
    Malacova, Eva
    Hurst, Cameron
    Johnson, David W.
    Mallett, Andrew J.
    KIDNEY INTERNATIONAL REPORTS, 2021, 6 (09): : 2481 - 2485
  • [43] Reduction in kidney function decline and risk of severe clinical events in agalsidase beta-treated Fabry disease patients: a matched analysis from the Fabry Registry
    Batista, Julie L.
    Hariri, Ali
    Maski, Manish
    Richards, Susan
    Gudivada, Badari
    Raynor, Lewis A.
    Ponce, Elvira
    Wanner, Christoph
    Desnick, Robert J.
    CLINICAL KIDNEY JOURNAL, 2024, 17 (08)
  • [44] Phenotype and Genotype Characterization and Twin Association in Patients with Anderson-Fabry Cardiomyopathy
    Gomez, Miquel
    Molina, Lluis
    Cladellas, Mercedes
    Ascoeta, Soledad
    Soler, Cristina
    Ble, Mireia
    Ramirez, Aleyska
    Bruguera, Jordi
    CARDIOLOGY, 2012, 121 (02) : 71 - 75
  • [45] Establishment and characterization of Fabry disease endothelial cells with an extended lifespan
    Shen, Jin-Song
    Meng, Xing-Li
    Schiffmann, Raphael
    Brady, Roscoe O.
    Kaneski, Christine R.
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (1-2) : 137 - 144
  • [46] Treatment outcomes for Hodgkin lymphoma: First report from the Brazilian Prospective Registry
    Biasoli, Irene
    Castro, Nelson
    Delamain, Marcia
    Silveira, Talita
    Farley, James
    Simoes, Belinda Pinto
    Solza, Cristiana
    Praxedes, Monica
    Baiocchi, Otavio
    Gaiolla, Rafael
    Franceschi, Fernanda
    Sola, Caroline Bonamin
    Boquimpani, Carla
    Clementino, Nelma
    Perini, Guilherme
    Pagnano, Katia
    Steffenello, Giovanna
    Tabacof, Jacques
    Colli, Gilberto de Freitas
    Soares, Andrea
    de Souza, Carmino
    Chiattone, Carlos Sergio
    Milito, Cristiane
    Morais, Jose Carlos
    Spector, Nelson
    HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 189 - 195
  • [47] Safety Observations in 12095 Patients With Psoriasis Enrolled in an International Registry (PSOLAR): Experience With Infliximab and Other Systemic and Biologic Therapies
    Gottlieb, Alice B.
    Kalb, Robert E.
    Langley, Richard G.
    Krueger, Gerald G.
    de Jong, Elke M. G. J.
    Guenther, Lynn
    Goyal, Kavitha
    Fakharzadeh, Steven
    Chevrier, Marc
    Calabro, Stephen
    Langholff, Wayne
    Menter, Alan
    JOURNAL OF DRUGS IN DERMATOLOGY, 2014, 13 (12) : 1441 - 1448
  • [48] Demographic, clinical, and functional characteristics of youth enrolled in six California systems of care
    Rosenblatt A.
    Rosenblatt J.
    Journal of Child and Family Studies, 2000, 9 (1) : 51 - 66
  • [49] New mutations in the GLA gene in Brazilian families with Fabry disease
    Turaca, Lauro Thiago
    Pessoa, Juliana Gilbert
    Motta, Fabiana Louise
    Munoz Rojas, Maria Veronica
    Mueller, Karen Barbosa
    Lourenco, Charles Marques
    Marques, Wilson Junior
    D'Almeida, Vania
    Martins, Ana Maria
    Pesquero, Joao Bosco
    JOURNAL OF HUMAN GENETICS, 2012, 57 (06) : 347 - 351
  • [50] Rationale and Design - BREATHE Registry-I Brazilian Registry of Heart Failure
    Albuquerque, Denilson
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2013, 100 (05) : 390 - 394